The upregulation of STOML2 could favor cyto-protective mitophagy via stabilizing PINK1 to facilitate cancer cell migration and invasion, relieve cellular stress, and regulate the sensitivity of HCC cells to lenvatinib. Here, STOML2 is linked to cancer.